AMA
Kurmuş G, Yılmaz EB, Kartal SP, Alper M. Early and significant improvement of rupioid psoriasis with bimekizumab. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(3):330-332. doi:10.5114/ada.2026.162865.
APA
Kurmuş, G., Yılmaz, E. B., Kartal, S. P., & Alper, M. (2026). Early and significant improvement of rupioid psoriasis with bimekizumab. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(3), 330-332. https://doi.org/10.5114/ada.2026.162865
Chicago
Kurmuş, Gökçe Işıl, Erkin B Yılmaz, Selda P Kartal, and Murat Alper. 2026. "Early and significant improvement of rupioid psoriasis with bimekizumab". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 43 (3): 330-332. doi:10.5114/ada.2026.162865.
Harvard
Kurmuş, G., Yılmaz, E., Kartal, S., and Alper, M. (2026). Early and significant improvement of rupioid psoriasis with bimekizumab. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 43(3), pp.330-332. https://doi.org/10.5114/ada.2026.162865
MLA
Kurmuş, Gökçe Işıl et al. "Early and significant improvement of rupioid psoriasis with bimekizumab." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 43, no. 3, 2026, pp. 330-332. doi:10.5114/ada.2026.162865.
Vancouver
Kurmuş G, Yılmaz E, Kartal S, Alper M. Early and significant improvement of rupioid psoriasis with bimekizumab. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2026;43(3):330-332. doi:10.5114/ada.2026.162865.
